BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6951664)

  • 1. Sialyltransferase activity as a marker for the differentiation of lymphocytes. Increase in sialyltransferase activity of blasts from acute lymphoblastic leukaemia cases by 12-o-tetradecanoylphorbol-13-acetate (TPA).
    Sasaki R; Takaku F; Lin YL; Bollum FJ
    Clin Exp Immunol; 1982 Feb; 47(2):381-8. PubMed ID: 6951664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
    Nagasawa K; Howatson A; Mak TW
    J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-0-Tetradecanoylphorbol 13-acetate (TPA)-induced enzymatic change of human non-T, non-B lymphoid leukemia cell lines.
    Sasaki R; Kubonishi I; Minowada J; Bollum FJ; Miura Y; Takaku F
    Haematologia (Budap); 1993; 25(2):111-21. PubMed ID: 8244198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialyltransferase activity in leukemia.
    Sasaki R; Takaku F; Lin YL; Bollum FJ
    Leuk Res; 1982; 6(2):199-202. PubMed ID: 7186087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester-induced differentiation of human T-lymphoblastic cell line HPB-ALL.
    Nakao Y; Matsuda S; Fujita T; Watanabe S; Morikawa S; Saida T; Ito Y
    Cancer Res; 1982 Sep; 42(9):3843-50. PubMed ID: 6179612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
    LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
    J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal deoxynucleotidyl transferase and glucocorticoid receptors in rat thymocytes.
    Sasaki R; Takaku F; Bollum FJ
    Haematologia (Budap); 1993; 25(3):165-78. PubMed ID: 8119629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-induced differentiation of a non-T/non-B human leukemic cell line (REH) to macrophage-like cells.
    Srivastava BI; Koga M; Srivastava P
    Cancer Res; 1984 Jul; 44(7):3017-21. PubMed ID: 6373000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of deoxyguanosine resistance by TPA-induced T lymphoid lines.
    Sacchi N; Fiorini G; Plevani P; Badaracco G; Breviario D; Ginelli E
    J Immunol; 1983 Apr; 130(4):1622-6. PubMed ID: 6601131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase IV activity in cells of T-lymphoid origin is decreased in cultures with 12-0-tetradecanoylphorbol-13-acetate (TPA).
    Lemez P; Koubek K; Malasková V; Lojda Z
    Haematologia (Budap); 1987; 20(3):165-70. PubMed ID: 2891591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of human T-cell differentiation markers by 12-O-tetradecanoylphorbol-13-acetate.
    Nagasawa K; Chechik BE; Gelfand EW; Sengupta S; Letarte M; Mak TW
    Thymus; 1981 Nov; 3(4-5):307-18. PubMed ID: 6274066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of non-T, non-B acute lymphocytic leukemia cells to phorbol ester.
    Okamura J; Gelfand EW; Letarte M
    Cancer Res; 1984 Mar; 44(3):1246-51. PubMed ID: 6581867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sialyltransferase activity in differentiation and malignant transformation of lymphocytes].
    Sasaki R; Lin YL; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1982 Nov; 45(6):1048-54. PubMed ID: 6961724
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kuliczkowski K; Noworolska A; Frydecka I; Sedek K; Harłozińska A
    Neoplasma; 1989; 36(5):589-97. PubMed ID: 2812152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate with cells in mixed-lymphocyte culture.
    Mastro AM; Krupa TA; Smith P
    Cancer Res; 1979 Oct; 39(10):4078-82. PubMed ID: 157802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal differentiation of human leukemic blasts in response to 12-0-tetradecanoyl-13-phorbol acetate (TPA).
    Joshi KS; Rao SG; Joshi DS; Advani SH; Bhisey AN
    Anticancer Res; 1988; 8(6):1367-71. PubMed ID: 3218970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lectin-stimulated DNA synthesis in bovine lymphocytes by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
    Mastro AM; Pepin KG
    Cancer Res; 1980 Sep; 40(9):3307-12. PubMed ID: 7191775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.